http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010195759-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53ee928be75b3cdf709f2c892a3f7842 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2009-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e74d8afa13fdf21fc3bcac4bbe97dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed7ac9aa7c90b7fb52f01bc0925d9e69 |
| publicationDate | 2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010195759-A |
| titleOfInvention | 1,4-benzothiazepine derivative, production method thereof and use thereof |
| abstract | Disclosed is a novel 1,4-benzothiazepine derivative or a pharmaceutically acceptable salt thereof useful for the treatment or prevention of heart failure, angina pectoris or myocardial infarction. The following general formula [I] [Wherein, R 1 represents a hydrogen atom or a hydroxyl group. Or a pharmaceutically acceptable salt thereof. The novel 1,4-benzothiazepine derivative or a pharmaceutically acceptable salt thereof gently dilates coronary blood vessels, increases oxygen supply to the myocardium, and reduces myocardial oxygen consumption. It is useful as a therapeutic or prophylactic agent for heart failure, angina pectoris or myocardial infarction. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8710045-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011172190-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021015221-A1 |
| priorityDate | 2009-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.